Skip to the guide

Semaglutide physicians

A guide to checking care

Put results in context

An average is not a promise.

Before using a study result to plan your care, ask who took part, what each group received and what the study cannot tell you.

Keep the comparison next to the result.

What a weight study found

STEP 1 studied adults who had obesity, meaning high body fat, or excess weight linked to a health problem.

They did not have diabetes, an illness that affects blood sugar.

At 68 weeks, semaglutide participants had lost an average of 14.9% of their weight. The dummy-injection group had lost 2.4% on average.

A dummy injection, called a placebo, contains no active medicine.

Besides their shots, each group received advice on daily habits and attended regular visits. The drug maker paid for the study.

The study summary used here does not describe that advice in detail. Ask your prescriber what it involved and what help would come with your care.

Those are group averages, and individual results vary.

Ask it plainly

How closely do the people in this study match my health?

What happened after stopping

The STEP 1 follow-up tracked the year after treatment stopped. Participants put back on about two-thirds of the weight they had lost.

Ask about a longer-term plan, including cost and a future decision to stop. The study gives a reason for that conversation.

Ask it plainly

How will we plan for continuing care or stopping later?

Ask what the claim rests on

Ask for the study behind a result being advertised. Ask who was studied and what they received besides medicine.

Look for the comparison group. A result without a comparison leaves an important question open.

Ask which result the prescriber expects to discuss at follow-up. Keep expectations specific to your health, not a headline.